• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁稳态调节与相关疾病。

Regulation of Iron Homeostasis and Related Diseases.

机构信息

Key Laboratory of Agro-Ecological Processes in Subtropical Region, Hunan Research Center of Livestock & Poultry Sciences, South-Central Experimental Station of Animal Nutrition and Feed Science in Ministry of Agriculture, Institute of Subtropical Agriculture, The Chinese Academy of Sciences, Changsha, Hunan 410125, China.

University of Chinese Academy of Sciences, Beijing 100049, China.

出版信息

Mediators Inflamm. 2020 May 2;2020:6062094. doi: 10.1155/2020/6062094. eCollection 2020.

DOI:10.1155/2020/6062094
PMID:32454791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7212278/
Abstract

The liver is the organ for iron storage and regulation; it senses circulating iron concentrations in the body through the BMP-SMAD pathway and regulates the iron intake from food and erythrocyte recovery into the bloodstream by secreting hepcidin. Under iron deficiency, hypoxia, and hemorrhage, the liver reduces the expression of hepcidin to ensure the erythropoiesis but increases the excretion of hepcidin during infection and inflammation to reduce the usage of iron by pathogens. Excessive iron causes system iron overload; it accumulates in never system and damages neurocyte leading to neurodegenerative diseases such as Parkinson's syndrome. When some gene mutations affect the perception of iron and iron regulation ability in the liver, then they decrease the expression of hepcidin, causing hereditary diseases such as hereditary hemochromatosis. This review summarizes the source and utilization of iron in the body, the liver regulates systemic iron homeostasis by sensing the circulating iron concentration, and the expression of hepcidin regulated by various signaling pathways, thereby understanding the pathogenesis of iron-related diseases.

摘要

肝脏是铁储存和调节的器官;它通过 BMP-SMAD 途径感知体内循环铁浓度,并通过分泌铁调素来调节食物中铁的摄入和红细胞回收到血液中的铁。在缺铁、缺氧和出血的情况下,肝脏会降低铁调素的表达,以确保红细胞生成,但在感染和炎症期间会增加铁调素的排泄,以减少病原体对铁的利用。过量的铁会导致系统铁过载;它在神经系统中积累并损害神经细胞,导致帕金森综合征等神经退行性疾病。当某些基因突变影响肝脏对铁的感知和铁调节能力时,就会降低铁调素的表达,从而导致遗传性血色病等遗传性疾病。本文综述了体内铁的来源和利用、肝脏通过感知循环铁浓度来调节全身铁平衡以及各种信号通路对铁调素表达的调节,从而了解铁相关疾病的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b73/7212278/6c8b2c9e1dbd/MI2020-6062094.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b73/7212278/5355a4996a93/MI2020-6062094.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b73/7212278/6c8b2c9e1dbd/MI2020-6062094.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b73/7212278/5355a4996a93/MI2020-6062094.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b73/7212278/6c8b2c9e1dbd/MI2020-6062094.002.jpg

相似文献

1
Regulation of Iron Homeostasis and Related Diseases.铁稳态调节与相关疾病。
Mediators Inflamm. 2020 May 2;2020:6062094. doi: 10.1155/2020/6062094. eCollection 2020.
2
Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis.亚铁转运蛋白与铁调素的相互作用控制着全身铁稳态。
Int J Mol Sci. 2021 Jun 17;22(12):6493. doi: 10.3390/ijms22126493.
3
Regulation of hepcidin and iron-overload disease.铁调素的调控与铁过载疾病
Annu Rev Pathol. 2009;4:489-515. doi: 10.1146/annurev.pathol.4.110807.092205.
4
Regulation of the Iron Homeostatic Hormone Hepcidin.铁稳态激素铁调素的调节
Adv Nutr. 2017 Jan 17;8(1):126-136. doi: 10.3945/an.116.013961. Print 2017 Jan.
5
Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.铁调素:铁代谢的稳态及相关疾病
Acta Haematol. 2017;137(4):220-236. doi: 10.1159/000471838. Epub 2017 May 18.
6
Hepcidin: regulation of the master iron regulator.铁调素:主要铁调节因子的调控
Biosci Rep. 2015 Mar 31;35(3):e00192. doi: 10.1042/BSR20150014.
7
Update on iron metabolism and molecular perspective of common genetic and acquired disorder, hemochromatosis.铁代谢更新以及常见遗传性和获得性疾病——血色素沉着症的分子视角
Crit Rev Oncol Hematol. 2015 Jul;95(1):12-25. doi: 10.1016/j.critrevonc.2015.02.006. Epub 2015 Feb 18.
8
Hepcidin and the BMP-SMAD pathway: An unexpected liaison.铁调素与骨形态发生蛋白-信号转导和转录激活因子(BMP-SMAD)通路:一种意想不到的联系。
Vitam Horm. 2019;110:71-99. doi: 10.1016/bs.vh.2019.01.004. Epub 2019 Feb 10.
9
Signaling pathways regulating hepcidin.调节铁调素的信号通路。
Vitam Horm. 2019;110:47-70. doi: 10.1016/bs.vh.2019.01.003. Epub 2019 Feb 6.
10
Testosterone perturbs systemic iron balance through activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin.睾酮通过激活肝脏中的表皮生长因子受体信号和抑制铁调素来扰乱全身铁平衡。
Hepatology. 2014 Feb;59(2):683-94. doi: 10.1002/hep.26648. Epub 2013 Dec 16.

引用本文的文献

1
The Relationship Between Non-Transferrin-Bound Iron (NTBI), Labile Plasma Iron (LPI), and Iron Toxicity.非转铁蛋白结合铁(NTBI)、不稳定血浆铁(LPI)与铁毒性之间的关系
Int J Mol Sci. 2025 Jul 3;26(13):6433. doi: 10.3390/ijms26136433.
2
Ferritinophagy in cardiovascular diseases: mechanisms and potential therapy.心血管疾病中的铁蛋白自噬:机制与潜在治疗方法
Mol Cell Biochem. 2025 Jun 20. doi: 10.1007/s11010-025-05301-3.
3
Genomic Insights into Vector-Pathogen Adaptation in and .对[具体内容1]和[具体内容2]中媒介-病原体适应性的基因组学见解。

本文引用的文献

1
MiR-20b Down-Regulates Intestinal Ferroportin Expression In Vitro and In Vivo.miR-20b 体外和体内下调肠道铁蛋白表达。
Cells. 2019 Sep 24;8(10):1135. doi: 10.3390/cells8101135.
2
Discovery and Development of TMPRSS6 Inhibitors Modulating Hepcidin Levels in Human Hepatocytes.发现和开发 TMPRSS6 抑制剂调节人肝细胞中血红素水平。
Cell Chem Biol. 2019 Nov 21;26(11):1559-1572.e9. doi: 10.1016/j.chembiol.2019.09.004. Epub 2019 Sep 19.
3
Identification and Functional Verification of MicroRNA-16 Family Targeting Intestinal Divalent Metal Transporter 1 (DMT1) and .
Pathogens. 2025 Mar 23;14(4):306. doi: 10.3390/pathogens14040306.
4
HFE-Related Hemochromatosis May Be a Primary Kupffer Cell Disease.与HFE相关的血色素沉着症可能是一种原发性库普弗细胞疾病。
Biomedicines. 2025 Mar 10;13(3):683. doi: 10.3390/biomedicines13030683.
5
Non-HFE Hemochromatosis in the Context of β-Thalassemia Trait: A Case Study on Iron Overload Dysregulation.β地中海贫血特征背景下的非HFE型血色素沉着症:铁过载失调的病例研究
Cureus. 2024 Nov 25;16(11):e74431. doi: 10.7759/cureus.74431. eCollection 2024 Nov.
6
Interplay of the heart, spleen, and bone marrow in heart failure: the role of splenic extramedullary hematopoiesis.心力衰竭中心、脾、骨髓的相互作用:脾髓外造血的作用。
Heart Fail Rev. 2024 Sep;29(5):1049-1063. doi: 10.1007/s10741-024-10418-6. Epub 2024 Jul 10.
7
Screening of key immunerelated gene in Parkinsons disease based on WGCNA and machine learning.基于 WGCNA 和机器学习的帕金森病关键免疫相关基因筛查。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Feb 28;49(2):207-219. doi: 10.11817/j.issn.1672-7347.2024.230307.
8
Zinc, Copper, and Iron in Selected Skin Diseases.某些皮肤病中的锌、铜和铁。
Int J Mol Sci. 2024 Mar 29;25(7):3823. doi: 10.3390/ijms25073823.
9
The Role of Calcium and Iron Homeostasis in Parkinson's Disease.钙和铁稳态在帕金森病中的作用
Brain Sci. 2024 Jan 17;14(1):88. doi: 10.3390/brainsci14010088.
10
Seasonal and fasting induced changes in iron metabolism in Djungarian hamsters.季节和禁食诱导的达乌尔黄鼠铁代谢变化。
PLoS One. 2023 Nov 6;18(11):e0293971. doi: 10.1371/journal.pone.0293971. eCollection 2023.
靶向肠二价金属转运蛋白1(DMT1)的微小RNA-16家族的鉴定与功能验证 以及
Front Physiol. 2019 Jun 27;10:819. doi: 10.3389/fphys.2019.00819. eCollection 2019.
4
Genotypic and phenotypic spectra of hemojuvelin mutations in primary hemochromatosis patients: a systematic review.原发性血色病患者血幼素基因突变的基因型和表型谱:系统评价。
Orphanet J Rare Dis. 2019 Jul 8;14(1):171. doi: 10.1186/s13023-019-1097-2.
5
Treatments for Iron Deficiency (ID): Prospective Organic Iron Fortification.缺铁治疗(ID):前瞻性有机铁强化。
Curr Pharm Des. 2019;25(3):325-332. doi: 10.2174/1381612825666190319111437.
6
The hemochromatosis protein HFE signals predominantly via the BMP type I receptor ALK3 in vivo.血色素沉着症蛋白HFE在体内主要通过BMP I型受体ALK3发出信号。
Commun Biol. 2018 Jun 8;1:65. doi: 10.1038/s42003-018-0071-1. eCollection 2018.
7
Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice.急性促红细胞生成素治疗后血清铁的短暂降低有助于铁调素在小鼠中被促红细胞生成素释放因子抑制。
Haematologica. 2019 Mar;104(3):e87-e90. doi: 10.3324/haematol.2018.199810. Epub 2018 Sep 28.
8
Erythroferrone inhibits the induction of hepcidin by BMP6.促红细胞生成素抑制 BMP6 诱导的铁调素表达。
Blood. 2018 Oct 4;132(14):1473-1477. doi: 10.1182/blood-2018-06-857995. Epub 2018 Aug 10.
9
Transferrin and transferrin receptors update.转铁蛋白和转铁蛋白受体更新。
Free Radic Biol Med. 2019 Mar;133:46-54. doi: 10.1016/j.freeradbiomed.2018.06.037. Epub 2018 Jun 30.
10
Transferrin Receptors TfR1 and TfR2 Bind Transferrin through Differing Mechanisms.转铁蛋白受体TfR1和TfR2通过不同机制结合转铁蛋白。
Biochemistry. 2018 Mar 6;57(9):1552-1559. doi: 10.1021/acs.biochem.8b00006. Epub 2018 Feb 12.